Related references
Note: Only part of the references are listed.MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
David B. Chapel et al.
MODERN PATHOLOGY (2020)
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach
Andrew G. Nicholson et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Cytoplasmic MTAP expression loss detected by immunohistochemistry correlates with 9p21 homozygous deletion detected by FISH in pleural effusion cytology of mesothelioma
Makoto Hamasaki et al.
HISTOPATHOLOGY (2019)
Genome doubling shapes the evolution and prognosis of advanced cancers
Craig M. Bielski et al.
NATURE GENETICS (2018)
Novel insights into mesothelioma biology and implications for therapy
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2017)
Human Peritoneal Mesothelial Cells Display Phagocytic and Antigen-Presenting Functions to Contribute to Intraperitoneal Immunity
Tanya J. Shaw et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Oligodendroglioma: pathology, molecular mechanisms and markers
Pieter Wesseling et al.
ACTA NEUROPATHOLOGICA (2015)
BAP1 Immunohistochemistry and p16 FISH to Separate Benign From Malignant Mesothelial Proliferations
Brandon S. Sheffield et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Fluorescence In Situ Hybridization in the Definitive Diagnosis of Malignant Mesothelioma in Effusion Cytology
Spasenija Savic et al.
CHEST (2010)
Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas
Simion Chiosea et al.
MODERN PATHOLOGY (2008)
Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth
MJ Hausmann et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
